Secondary prevention of osteoporotic fractures: evaluation of the Amiens University Hospital’s fracture liaison service between January 2010 and December 2011

Osteoporosis International

Volumn 25, Issue 10, 2014, Pages 2409-2416

  Dehamchia Rehailia, N ^a   Ursu, D ^a   Henry Desailly, I ^a   Fardellone, P ^a   Paccou, J ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

Fracture; Fracture liaison service; Osteoporosis; Persistence

Indexed keywords

ALENDRONIC ACID; IBANDRONIC ACID; RALOXIFENE; RISEDRONIC ACID; STRONTIUM RANELATE; ZOLEDRONIC ACID; BONE DENSITY CONSERVATION AGENT;

ADULT; AGED; ANKLE FRACTURE; ARTICLE; BONE DENSITY; CALCIUM INTAKE; EVALUATION STUDY; FEMALE; FRAGILITY FRACTURE; HIP FRACTURE; HOSPITAL SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; OBSERVATIONAL STUDY; OSTEOPOROSIS; OUTCOME ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; SHOULDER FRACTURE; UNIVERSITY HOSPITAL; WRIST FRACTURE; DRUG SUBSTITUTION; DRUG UTILIZATION; FRANCE; INTEGRATED HEALTH CARE SYSTEM; KAPLAN MEIER METHOD; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; OSTEOPOROTIC FRACTURES; PROCEDURES; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; BONE DENSITY CONSERVATION AGENTS; DELIVERY OF HEALTH CARE, INTEGRATED; DRUG SUBSTITUTION; DRUG UTILIZATION; FEMALE; FRANCE; HOSPITALS, UNIVERSITY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MEDICATION ADHERENCE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; SECONDARY PREVENTION;

EID: 84919455432     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-014-2774-6     Document Type: Article

References (31)

1. Maravic M, Taupin P, Landais P, Roux C (2011) Change in hip fracture incidence over the last 6 years in France. Osteoporos Int 22:791–801
2. Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301:513–521
3. Leboime A, Confavreux CB, Mehsen N, Paccou J, David C, Roux C (2010) Osteoporosis and mortality. Joint Bone Spine 77(2):S107–S112
4. Bliuc D, Nguyen ND, Nguyen TV, Eisman JA, Center JR (2013) Compound risk of high mortality following osteoporotic fracture and refracture in elderly women and men. J Bone Miner Res 28:2317–2324
5. Body JJ, Bergmann P, Boonen S, Boutsen Y, Devogelaer JP, Goemaere S et al (2010) Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club. Osteoporos Int 21:1657–1680
6. Bolland MJ, Grey AB, Gamble GD, Reid IR (2010) Effect of osteoporosis treatment on mortality: a meta-analysis. J Clinic Endocrinol Metab 95:1174–1181
7. Cranney A, Guyatt G, Griffith L, Wells G, Tugwell P, Rosen C et al (2002) Meta-analyses of therapies for postmenopausal osteoporosis. IX: summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 23:570–578
8. Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Eng J Med 361:756–765
9. Lyles KW, Colon-Emeric CS, Magaziner JS (2007) HORIZON Recurrent Fracture Trial. Zoledronic acid and clinical fractures and mortality after hip fracture. N Eng J Med 357:1799–1809
10. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX® and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385–397
11. Briot K, Cortet B, Thomas T, Audran M, Blain H, Breuil V et al (2012) 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis. Joint Bone Spine 79:304–313
12. Eisman JA, Bogoch ER, Dell R, Harrington JT, McKinney RE Jr, McLellan A et al (2012) Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention. J Bone Miner Res 27:2039–2046
13. Boudou L, Gerbay B, Chopin F, Ollagnier E, Collet P, Thomas T (2011) Management of osteoporosis in fracture liaison service associated with long-term adherence to treatment. Osteoporos Int 22:2099–2106
14. Ganda K, Puech M, Chen JS, Speerin R, Bleasel J, Center JR et al (2013) Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis. Osteoporos Int 24:393–406
15. Eekman DA, van Helden SH, Huisman AM, Verhaar HJJ, Bultink IEM, Geusens PP et al (2014) Optimizing fracture prevention: the fracture liaison service, an observational study. Osteoporos Int 25:701–709
16. Vaile JH, Sullivan L, Connor D, Bleasel JF (2013) A year of fractures: a snapshot analysis of the logistics problems and outcomes of a hospital-based fracture liaison service. Osteoporos Int 24:2619–2625
17. Akesson K, Marsh D, Mitchell PJ, McLellan AR, Stenmark J, Pierroz DD et al (2013) Capture the fracture: a best practice framework and global campaign to break the fragility fracture cycle. Osteoporos Int 24:2135–2152
18. Cooper C, Mitchell P, Kanis JA (2011) Breaking the fragility fracture cycle. Osteoporos Int 22:2049–2050
19. Huntjens KM, van Geel TC, Geusens PP, Winkens B, van den Bergh J, Brink PR et al (2011) Impact of guideline implementation by a fracture nurse on subsequent fractures and mortality in patients presenting with non-vertebral fractures. Injury 42(4):39–43
20. McLellan AR, Gallacher SJ, Fraser M, McQuillian C (2003) The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporos Int 14:1028–1034
21. Gallacher SJ (2005) Setting up an osteoporosis fracture liaison service: background and potential outcomes. Best Pract Res Clin Rheumatol 19:1081–1094
22. Huntjens KM, van Geel TA, Blonk MC, Hegeman JH, van der Elst M, Willems P (2011) Implementation of osteoporosis guidelines: a survey of five large fracture liaison services in the Netherlands. Osteoporos Int 22:2129–2135
23. Ojeda-Bruno S, Naranjo A, Erausquin C, Francisco-Hernandez F, Rua-Figueroa I, Quevedo JC et al (2011) Secondary prevention program for osteoporotic fractures and long-term adherence to bisphosphonates. Osteoporos Int 22:1821–1828
24. Chandran M, Tan MZ, Cheen M, Tan SB, Leong M, Lau TC (2013) Secondary prevention of osteoporotic fractures—an “OPTIMAL” model of care from Singapore. Osteoporos Int 24:2809–2817
25. Premaor MO, Pilbrow L, Tonkin C, Adams M, Parker RA, Compston J (2010) Low rates of treatment in postmenopausal women with a history of low trauma fractures: results of audit in a fracture liaison service. Q J Med 103:33–40
26. Prieti-Alhambra D, Judge A, Adren NK, Cooper C, Lyles KW, Javaid MK (2014) Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial. Osteoporos Int 25:77–83
27. Diab DL, Watts NB (2014) Denosumab in osteoporosis. Expert Opin Drug Saf 13:247–253
28. Howat I, Carty D, Harrison J, Fraser M, McLellan AR (2007) Vertebral fracture assessment in patients presenting with incident nonvertebral fractures. Clin Endocrinol 67:923–930
29. Gallacher SJ, Gallagher AP, McQuillian C, Mitchell PJ, Dixon T (2007) The prevalence of vertebral fracture amongst patients presenting with non-vertebral fractures. Osteoporos Int 18:185–192
30. Paccou J, Confavreux CB, David C, Leboime A, Mehsen N, Cortet B (2010) Stabilized severe osteoporosis: should the treatment be stopped? Joint Bone Spine 77:120–127
31. Streeten EA, Mohamed A, Gandhi A, Orwig D, Sack P, Sterling R et al (2006) The inpatient consultation approach to osteoporosis treatment in patients with a fracture. Is automatic approach to osteoporosis needed? J Bone Joint Surg Am 88:1968–1974